Pradaxa Bleeding Side Effects Lawsuit
Pradaxa Life-Threatening Side Effects. Have you or a loved one suffered a life-threatening Pradaxa bleeding side effect? By the end of 2011 – little more than a year after the blood-thinning medication was approved for use in the U.S. – the maker of ‘Pradaxa’ acknowledged that there had been least 260 deaths among people who suffered serious Pradaxa bleeding side effects. Parker Waichman LLP is currently investigating ‘Pradaxa’ side effect reports, including:
- Life-threatening internal bleeding
- Gastrointestinal hemorrhaging/bleeding
- Cerebral hemorrhaging/bleeding
- Ulcers
- Death
If you or a loved one suffered a serious, life-threatening ‘Pradaxa’ side effects, especially internal bleeding, you may be entitled to receive compensation for your medical bills, lost wages, pain and suffering, emotional distress and other damages. The Pradaxa bleeding side effect lawyers at Parker Waichman LLP are currently offering free consultations to anyone injured by this drug. To discuss a potential Pradaxa bleeding side effect lawsuit with one of our experienced and dedicated defective drug lawyers, please contact Parker Waichman LLP today.
Pradaxa Bleeding Side Effects Reports
Manufactured by Boehringer Ingelheim, ‘Pradaxa’ was approved by the U.S. Food & Drug Administration (FDA) in October 2010 to prevent blood clots and strokes in people with atrial fibrillation. ‘Pradaxa’, part of a class of drugs known as Direct Thrombin Inhibitors, has been touted as an improvement over warfarin, a blood thinner that has been widely used for years.
Since its U.S. approval, ‘Pradaxa’ has been the subject of an increasing number of Pradaxa bleeding side effect reports. In late 2011, Boehringer Ingleheim acknowledged that between March 2008 and October 31, 2011, it had received 260 reports worldwide of deaths related to Pradaxa bleeding side effects. In August 2011, after 81 elderly ‘Pradaxa’ patients, including 5 who died, suffered serious bleeding events in Japan, regulators in that country ordered Boehringer to warn doctors about dangerous bleeding side effects. Just months later, in October 2011, European regulators recommended that new information be added to the Pradaxa because of reports of bleeding side effects that were fatal. Finally, in December 2011, the FDA announced it was evaluating post-marketing reports of serious bleeding side effects in patients taking Pradaxa.
While warfarin also poses a risk of serious bleeding events, warfarin bleeding can be treated with vitamin K. However, there is no antidote for ‘Pradaxa’ bleeding side effects, other than discontinuing the drug. As a result, Pradaxa bleeding side effects are extremely dangerous and should be reported to a doctor immediately. Symptoms of ‘Pradaxa’ side effects include:
- Lethargy and fatigue
- Unusual bruising or bleeding / hemorrhaging
- Pink or brown urine
- Red or black tarry stools
- Coughing up blood
- Vomiting that resembles blood or looks like coffee grounds
- Bleeding from the gums
- Frequent nosebleeds
- Joint pain or swelling
- Headaches
- Dizziness
- Weakness and swelling of the arms, hands, feet, ankles or lower legs
- Menstrual or vaginal bleeding that is heavier than normal
No Antidote For Pradaxa Bleeding
‘Pradaxa’ was brought to market with great fanfare, with its maker touting it as being safer than traditional blood thinners, like warfarin (brand names Coumadin, Jantoven and Marfarin). And it is true that ‘Pradaxa’ will not react with certain foods the way warfarin will to increase the likelyhood of bleeding events. However, warfarin bleeding can be stopped via the administration of vitamin K. There is no antidote for ‘Pradaxa’ bleeding at this time, making ‘Pradaxa’ bleeding events potentially far more deadly.
More on Eliquis
Eliquis (apixaban)
Daily Aspirin Risks
Pradaxa/Atrial Fibrillation
Need Legal Help
Regarding Pradaxa?
The personal injury attorneys at Parker Waichman LLP offer free, no-obligation case evaluations. For more information, fill out our online contact form or call 1-800-YOURLAWYER (1-800-968-7529).